Navigation Links
Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
Date:3/13/2008

436,990

Research and

development 7,288,460 2,678,749 20,554,105 9,214,759

Selling, general and

administrative 3,946,050 2,374,984 11,155,194 6,912,853

Total Operating

Expenses 11,263,739 5,095,132 31,949,728 16,564,602

LOSS FROM OPERATIONS (9,925,830) (4,668,805) (28,150,207) (15,582,856)

Interest income 1,217,439 290,842 4,254,024 830,870

NET LOSS $(8,708,391) $(4,377,963) $(23,896,183) $(14,751,986)

Basic and diluted net

loss per share $(0.11) $(0.07) $(0.32) $(0.24)

Shares used in computing

net loss per share,

basic and diluted 77,459,803 65,402,770 74,317,930 62,610,265

HALOZYME THERAPEUTICS, INC.

CONSOLIDATED BALANCE SHEETS

AS OF DECEMBER 31, 2007 AND 2006

2007 2006

ASSETS:

Cash and cash equivalents $97,679,085 $44,189,403

Accounts receivable 779,825 363,565

Inventory 703,468 442,492

Prepaid expenses and other assets 2,014,680 598,090

Total current assets 101,177,058 45,593,550

Property and equipment, net 2,283,316 497,770

Total Assets $103,460,374 $46,091,320

LIABILITIES AND STOCKHOLDERS' EQUITY:

Accounts payable $3,055,637 $2,017,395

Accrued expenses 2,502,259 1,011,153

Deferred revenue 3,306,225 1,221,992

Total current liabilities 8,864,121 4,250,540
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
2. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
3. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
4. Halozyme Therapeutics Amends Stockholder Rights Plan
5. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
6. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
7. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
10. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
11. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Selexis SA, a serial innovation company with ... used for drug discovery to commercial manufacturing, announced today ... Next-Generation Sequencing (NGS) data packages. The NGS analysis ... ensuring the integrity of the gene, validation of the ...
(Date:1/22/2015)...  Varian Medical Systems (NYSE: VAR ), world leader ... commitment to sustainability with inclusion on a prestigious list of ... healthcare equipment company among the Corporate Knights Global 100 Most ... at Davos, Switzerland . ...
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: UTHR ... MDT ) has submitted a pre-market approval application to ... use of Medtronic,s SynchroMed ® II implantable drug ... with United Therapeutics, Remodulin ® (treprostinil) Injection delivered ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by Instrument (Liquid ... Valves, Guages, Seals), Accessories, Services, End User (Biotechnology, ... provides a detailed overview of the major drivers, ... impacting the preparative and process chromatography market along ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... Calif., March 23 Based on its ... market, Frost & Sullivan presents Nanopoint, Inc. ... Sullivan Award for Product Innovation of the ... represents a highly sophisticated, on-microscope incubator and ...
... 23 PCI Biotech Holding ASA, the Norwegian,drug delivery ... announced that a PCI Biotech-led consortium focused on,effective siRNA ... more than 300,European projects and will receive EUR 1.1 ... The consortium comprises three companies PCI ...
... Fund Will Invest in Biotech Start-up Companies Focused on ... March 23 Merck Serono, a division of Merck ... Serono Ventures, a strategic, corporate venture capital fund to ... biotech start-up companies that have the potential to provide ...
Cached Biology Technology:Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 2Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 3Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 4Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 5PCI Biotech-led Consortium Awarded EUR1.1 m Eurostars Grant for siRNA 2Merck Serono Launches Strategic Venture Capital Fund 2Merck Serono Launches Strategic Venture Capital Fund 3
(Date:12/19/2014)... Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced the addition ... Systems Market" report to their offering. ... security market is estimated to grow at a CAGR of ... a larger share in this market, Canada ...
(Date:12/17/2014)... Dec. 15, 2014 Research and Markets ( ... "Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 Based on ... Samsung introduces for the first time a fingerprint sensor ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor technology, ... such as Intel, Jabra, Atlas, and Scosche to develop ... products will be showcased at CES 2015, taking place ... "Our partners choose PerformTek biometrics, because ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... Wheat has ways to battle the tiny, red wormlike ... destroy crops worldwide, but the Hessian fly larvae that ... Purdue University and USDA-Agriculture Research Service scientists trying to ... nullify toxins that wheat produces to protect itself from ...
... that contain high levels of action, such as Unreal Tournament, ... University of Rochester have shown that people who played action ... course of a month improved by about 20 percent in ... test similar to ones used in regular ophthalmology clinics. ...
... An international team led by researchers from the National ... Institutes of Health (NIH), has identified a genetic variant ... dogs. The findings appear in the April 6, 2007 ... characterization of a key genetic variant that accounts for ...
Cached Biology News:Scientists find genes involved in the battle between Hessian flies and wheat 2Scientists find genes involved in the battle between Hessian flies and wheat 3Action video games sharpen vision 20 percent 2Researchers identify gene involved in dog size 2Researchers identify gene involved in dog size 3Researchers identify gene involved in dog size 4
Goat polyclonal to STMN2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AKTAMAYKEK, corresponding to C terminal amino acids 2-11 of STMN2. Entrez Gene ID: 11075 Swi...
Mouse monoclonal antibody to PAEP - progestagen-associated endometrial protein (placental protein 14, pregnancy-associated endometrial alpha-2-globulin, alpha uterine protein)...
Mouse polyclonal antibody to MCFD2 - multiple coagulation factor deficiency 2...
Volume adapter mounts on top of the 96 well FiltrEX filter plate and allows larger volumes (1mL) to be applied to each well in a filter plate. Adapters are nonsterile....
Biology Products: